Therapy Areas: AIDS & HIV
Innoplexus uses AI discovery platform to find potential combinations of prior approved drugs for COVID-19
27 March 2020 - AI-based drug discovery and development company Innoplexus AG on Thursday provided an update of the first results from its artificial intelligence enabled search for a COVID-19 antivir...
Innoplexus reveals certain first results in artificial intelligence enabled search for COVID-19 treatment
27 March 2020 - Innoplexus AG, a global AI-based platform for drug discovery and development, has revealed certain first results in its artificial intelligence enabled search for a COVID-19 antiviral ...
Eargo Dials Up Service and Support for All Those With Hearing Loss During Coronavirus (COVID-19) Emergency
23 March 2020 - - In light of the temporary closure of hearing care centers across America due to the ongoing COVID-19 pandemic, hearing aid company Eargo announced it will be expanding support and se...
Health Canada approves Janssen Pharmaceutical's CABENUVA
23 March 2020 - Health Canada has approved CABENUVA (cabotegravir and rilpivirine extended release injectable suspensions), a product from Johnson & Johnson's Janssen Pharmaceutical Companies...
Former FDA Official Joins Sema4 Board of Directors
18 March 2020 - - US-based health intelligence company Sema4 has appointed Rachel Sherman, MD, MPH, to its board of directors, the company said.

Dr. Sherman is the former Principal Deputy...
Gilead Presents 96-week DISCOVER Trial Data Demonstrating Favourable Renal and Bone Safety Profile of Descovy for HIV PrEP in At-Risk Populations
12 March 2020 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) has presented longer-term results from the DISCOVER trial of Descovy (emtricitabine 200 mg and tenofovir alafe...